The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients

February 6, 2024 updated by: Chang-Qing Gao
Previous studies have demonstrated that sniff dogs can identify cancer patients from healthy subjects through sniffing exhaled breath air or blood or serum or urine or feces. It is hypothesized that sniff dogs may be used as a tool in identifying cancer patients in the high risk population or suspected patients. Trained dogs will sniff serum from participants who are suspected to suffer from tumor by their physicians and not yet but will be diagnosed by pathological examination.The results will be compared with the outcome of the pathological examination.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ya-Qin Wang, MD PhD
  • Phone Number: 86 15274810930
  • Email: wdove.bb@163.com

Study Contact Backup

  • Name: Chang-Qing Gao, MD PhD
  • Phone Number: 86 188 7486 9488
  • Email: cgao851@126.com

Study Locations

    • Hunan
      • Changsha, Hunan, China, 410008
        • Recruiting
        • Center for Scientific Research with Animal Models, CSU
        • Contact:
        • Contact:
          • Chang-Qing Gao, MD PhD
          • Phone Number: 86 188 7486 9488
          • Email: cgao851@126.com
        • Principal Investigator:
          • Chang-Qing Gao, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

  • Healthy volunteers who have been examined by the currently used procedures and find to be without tumors.
  • Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors

Description

Inclusion Criteria:

  • Healthy volunteers who have been examined by the currently used procedures and find to be without tumors.
  • Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors

Exclusion Criteria:

  • Patients who have had pathological results

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Healthy volunteers
Healthy volunteers measured by currently used healthy screening procedures
Suspected breast cancer subjects
Suspected breast cancer subjects without pathological examination yet but will have it soon
Suspected lung cancer subjects
Suspected lung cancer subjects without pathological examination yet but will have it soon
Suspected neurological tumor subjects
Suspected neurological tumor subjects without pathological examination yet but will have it soon
Suspected patients with gynecological tumor
Suspected subjects with gynecological tumors without pathological examination yet but will have it soon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sensitivity and specificity of the sniff dogs as a tool in diagnosing tumors
Time Frame: 12 months
The results that obtained from the dogs will be compared with these of the pathological examinations. Sensitivity = the No. of patients identified by the dogs as cancers / the No. of patients suffering from cancer confirmed by pathological examination. Specificity = No. of subjects signaled by the dog as non-cancers / No. of subjects confirmed by pathological examination as non-cancer subjects.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
behavior patterns of the sniff dogs to different diseases
Time Frame: 12 months
The behavior (lying before the tank for positive, neglecting the tanks) of the dog will be recorded and compared with the results of the pathological examination.
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
the substances used for identifying tumors by the sniff dogs
Time Frame: 12 months
GCMS etc will be used to compare the volatile compounds between the sera from cancers patients and the from non-cancer subjects, the suspected VOCs will be tested by the dog for conformation.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Chang-Qing Gao, MD PhD, Central South University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

January 26, 2014

First Submitted That Met QC Criteria

January 28, 2014

First Posted (Estimated)

January 30, 2014

Study Record Updates

Last Update Posted (Actual)

February 8, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Xiang-Ya 0003
  • XY 0003

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neoplasia

3
Subscribe